2 healthcare shares with dividend yields over 6.5%

The IVF providers have high yields and could be great long-term investments.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The two largest IVF providers in Australia are Monash IVF Group Ltd (ASX: MVF) and Virtus Health Ltd (ASX: VRT).

IVF is a very important procedure for the patient and families involved. Here are a few reasons why IVF providers could be a good long-term investment:

Families are having children at an older age

There are many more couples who are both working than in previous generations.

Families are making a conscious decision to delay having children and work hard in their careers or business to get as far ahead as possible.

The older we become the harder it is to create a child and the more likely it is that families will require assisted reproduction techniques.

Monash IVF and Virtus are perfectly placed to benefit the most with their multitude of businesses to assist patients.

New treatments unlock more possible IVF cycles

IVF technology has come a long way in the few decades that it has been operational.

Every advance that is developed creates more potential patients and customers.

There is now a range of techniques that can be used. Unexplainable infertility conditions today perhaps might be treatable in a few years, but this will cost the most of course, as brand-new treatments often do.

Big dividend payers

Most healthcare businesses don't have very big dividend yields, stocks like CSL Limited (ASX: CSL) and ResMed Inc. (CHESS) (ASX: RMD) have yields under 2%.

However, Monash IVF has a grossed-up dividend yield of 6.67% and Virtus has a grossed-up dividend yield of 7.09%.

They have such high yields because they trade on quite low earnings multiples and they have high dividend payout ratios. Monash IVF is trading at 14x FY17's estimated earnings with a payout ratio of 67%. Virtus is trading at 14x FY17's estimated earnings with a payout ratio of 71%.

Foolish takeaway

I think both companies are worth being on my watchlist. I like Monash IVF because it seems to be performing better in Australia whilst Virtus has a much bigger overseas segment to its business.

For some growth stocks that could be even better than Monash IVF and Virtus, you should check this out.

Motley Fool contributor Tristan Harrison has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »